Colleen Beauregard is head of global R&D communications at Takeda Pharmaceutical Company, Ltd. and a member of the R&D Management Committee (RMC). Prior to joining Takeda, Beauregard served as executive vice president of Feinstein Kean Healthcare, a strategic communications firm with an emphasis on transformative innovation in healthcare. Prior to Feinstein Kean Healthcare, she served as assistant vice president of corporate communications at The TJX Companies. Earlier in her career, she spent seventeen years at Waggener Edstrom Worldwide. In 2001, she co-founded the company’s healthcare practice, building it from two employees in one office to more than thirty employees in eight offices across North America, Europe, and Asia-Pacific. She was named general manager of the eastern region in June 2012 and was a member of the agency’s North America Advisory Board. Beauregard received a graduate certificate in business and administration from Harvard University and BA in communications with a minor in history from Hofstra University.